• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Collegium Pharmaceutical

edit

Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of proprietary, late stage pharmaceutical products. These products address the growing problems associated with non-medical use and abuse of prescription drugs through formulation based improvements protected by intellectual property (IP). Collegium is focused on building a portfolio of products for the treatment of chronic pain that possess tamper-resistant features and provide extended-release delivery using its patent protected DETERx™ formulation platform.

Recent Milestones

edit

• 
  Collegium Pharmaceutical received $22.5M in Venture Round funding. (2/15/12)
  Posted 2/22/12 at 5:39am via masshightech.com
• 
  Collegium Pharmaceutical added Michael Heffernan as Co-Founder, President, CEO.
  Posted 2/22/12 at 5:42am
• 
  Collegium Pharmaceutical added Heow Tan as Vice President of Technical Operations.
  Posted 2/22/12 at 5:42am

Videos

Screenshots

edit

Above: Collegium Pharmaceutical
Uploaded: 2/22/12

Sources

1. Collegium collects $22.5M in new fundraise (masshightech.com) [edit]